| Analysis | Metabolite Name | Measured Value | Units | Sample source | Factor |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 65941836 | Raw Peak Area | Colonic mucosa | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 69405056 | Raw Peak Area | Colonic mucosa | GF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 73529800 | Raw Peak Area | Colonic mucosa | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 75104256 | Raw Peak Area | Colonic mucosa | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 80867704 | Raw Peak Area | Colonic mucosa | GF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 82070488 | Raw Peak Area | Colonic mucosa | ColGF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 85041216 | Raw Peak Area | Colonic mucosa | ColGF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 86558744 | Raw Peak Area | Colonic mucosa | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 86964832 | Raw Peak Area | Colonic mucosa | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 88732592 | Raw Peak Area | Colonic mucosa | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 89469744 | Raw Peak Area | Colonic mucosa | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 89849472 | Raw Peak Area | Colonic mucosa | ColGF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 90222040 | Raw Peak Area | Colonic mucosa | ColGF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 91788344 | Raw Peak Area | Colonic mucosa | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 92671848 | Raw Peak Area | Colonic mucosa | GF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 93329296 | Raw Peak Area | Colonic mucosa | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 95656152 | Raw Peak Area | Colonic mucosa | GF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 96094824 | Raw Peak Area | Colonic mucosa | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 99124160 | Raw Peak Area | Colonic mucosa | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 99348456 | Raw Peak Area | Colonic mucosa | ColGF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 101097448 | Raw Peak Area | Colonic mucosa | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 103335384 | Raw Peak Area | Colonic mucosa | ColGF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 104405368 | Raw Peak Area | Colonic mucosa | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 106107616 | Raw Peak Area | Colonic mucosa | ColGF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 106885360 | Raw Peak Area | Colonic mucosa | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 107601432 | Raw Peak Area | Colonic mucosa | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 110193112 | Raw Peak Area | Colonic mucosa | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 111747184 | Raw Peak Area | Colonic mucosa | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 111809344 | Raw Peak Area | Colonic mucosa | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 112870752 | Raw Peak Area | Colonic mucosa | GF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 113136600 | Raw Peak Area | Colonic mucosa | GF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 113242000 | Raw Peak Area | Colonic mucosa | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 113347392 | Raw Peak Area | Colonic mucosa | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 114729416 | Raw Peak Area | Colonic mucosa | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 114745088 | Raw Peak Area | Colonic mucosa | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 117512000 | Raw Peak Area | Colonic mucosa | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 121451568 | Raw Peak Area | Colonic mucosa | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 123161592 | Raw Peak Area | Colonic mucosa | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 125001288 | Raw Peak Area | Colonic mucosa | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 127025272 | Raw Peak Area | Colonic mucosa | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 127344680 | Raw Peak Area | Colonic mucosa | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 128221568 | Raw Peak Area | Colonic mucosa | GF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 132731200 | Raw Peak Area | Colonic mucosa | GF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 133282048 | Raw Peak Area | Colonic mucosa | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 133398816 | Raw Peak Area | Colonic mucosa | GF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 133450720 | Raw Peak Area | Colonic mucosa | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 133572584 | Raw Peak Area | Colonic mucosa | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 134293280 | Raw Peak Area | Colonic mucosa | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 135336080 | Raw Peak Area | Colonic mucosa | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 136415424 | Raw Peak Area | Colonic mucosa | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 139657136 | Raw Peak Area | Colonic mucosa | GF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 139670208 | Raw Peak Area | Colonic mucosa | GF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 139963200 | Raw Peak Area | Colonic mucosa | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 141874304 | Raw Peak Area | Colonic mucosa | GF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 142843392 | Raw Peak Area | Colonic mucosa | GF_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 143043488 | Raw Peak Area | Colonic mucosa | GF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 145031552 | Raw Peak Area | Colonic mucosa | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 146116336 | Raw Peak Area | Colonic mucosa | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 147644016 | Raw Peak Area | Colonic mucosa | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 149165296 | Raw Peak Area | Colonic mucosa | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 152563072 | Raw Peak Area | Colonic mucosa | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 154629728 | Raw Peak Area | Colonic mucosa | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 172931968 | Raw Peak Area | Colonic mucosa | Conv_0min |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|